haloperidol has been researched along with kainic acid in 76 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 42 (55.26) | 18.7374 |
| 1990's | 24 (31.58) | 18.2507 |
| 2000's | 8 (10.53) | 29.6817 |
| 2010's | 2 (2.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ang, KK; Arkin, MR; Chen, S; Doyle, PS; Engel, JC; McKerrow, JH | 1 |
| Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
| Argiolas, A; Di Chiara, G; Gessa, GL; Porceddu, ML; Tissari, HA | 1 |
| Di Chiara, G; Gessa, GL; Morelli, M; Onali, PL; Porceddu, ML; Tissari, AH | 1 |
| Bunney, BS; Grace, AA | 1 |
| Bugatti, A; Cattabeni, F; Di Giulio, AM; Galli, CL; Groppetti, A; Parenti, M; Racagni, G | 1 |
| Freed, WJ; Neckers, LM; Perlow, MJ; Rosenblatt, JE; Shore, D; Wyatt, RJ | 1 |
| Biggio, G; Casu, M; Corda, MG; Gessa, GL | 2 |
| Biggio, G; Casu, M; Corda, MG; Gessa, GL; Mulas, ML | 1 |
| Iwama, K; Iwatsubo, K; Nakamura, S; Tsai, CT | 1 |
| Leysen, JE | 1 |
| De Montis, GM; Olianas, MC; Scheel-Krüger, J; Serra, G; Tagliamonte, A | 1 |
| Di Chiara, G; Gessa, GL; Morelli, M; Mulas, ML; Porceddu, ML | 1 |
| Coyle, JT; Creese, I; Schwarcz, R; Snyder, SH | 1 |
| Govoni, S; Spano, PF; Tonon, GC; Trabucchi, M | 1 |
| Ho, MT; Lin, MT; Young, MS | 1 |
| Diana, M; Groves, PM; Young, SJ | 1 |
| Dowling, JE; Knapp, AG; Schmidt, KF | 1 |
| Calder, LD; Karler, R; Turkanis, SA | 1 |
| Church, J; Lodge, D | 1 |
| De Montigny, C; Debonnel, G; Junien, JL; Monnet, FP | 1 |
| Honoré, T; Imperato, A; Jensen, LH | 1 |
| de Montigny, C; Debonnel, G; Monnet, FP | 1 |
| Dowling, JE; Rodrigues, Pdos S | 1 |
| Bonnet, JJ; Costentin, J; Valchár, M | 1 |
| Kirsch, M; Kohler, K; Wagner, HJ; Weiler, R | 1 |
| Deckel, AW; Moran, TH; Robinson, RG | 1 |
| Baran, H; Hornykiewicz, O; Hörtnagl, H; Sapetschnig, G; Sperk, G | 1 |
| Csernansky, JG; Glick, S; Mellentin, J | 1 |
| Biggio, G; Giorgi, O; Mele, S; Ongini, E; Porceddu, ML | 1 |
| Gonzalez, M; Infante, C; Leiva, J; Motles, E; Saavedra, H | 1 |
| Carvey, PM; Kao, LC; Klawans, HL | 1 |
| Kato, S; Negishi, K; Teranishi, T | 1 |
| Kikkert, RJ; Westerink, BH | 1 |
| Shinba, T; Sugita, R; Watabe, K | 1 |
| Moore, KE; Wuerthele, SM | 1 |
| Bannon, MJ; Bunney, EB; Roth, RH; Skirboll, LR; Zigun, JR | 1 |
| Nurk, AM; Zharkovskiĭ, AM | 1 |
| Argiolas, A; Fadda, F; Gessa, GL; Melis, MR | 1 |
| Krauss, J; Meyer, DK | 1 |
| Mark, RF; Sanberg, PR | 1 |
| Czuczwar, SJ; Kleinrok, Z; Turski, L; Turski, W | 1 |
| Di Chiara, G; Imperato, A; Morelli, M; Porceddu, ML | 1 |
| Sanberg, PR | 1 |
| Fibiger, HC; Pisa, M; Sanberg, PR | 1 |
| Allikmets, LH; Nurk, AM; Rägo, LK; Zarkovsky, AM | 1 |
| Bernard, PS; Liebman, JM; Pastor, G; Saelens, JK | 1 |
| Morgenstern, R | 1 |
| Arbilla, S; Kamal, LA; Langer, SZ | 1 |
| Lloyd, KG; Willigens, MT; Worms, P | 1 |
| Jenner, P; Marsden, CD; Reavill, C; Taylor, RJ | 1 |
| Iwatsubo, K; Kondo, Y | 1 |
| Elazar, Z; Paz, M; Peleg, N; Ring, G | 1 |
| Larson, AA; Sun, X | 4 |
| Brun, P; Le Fur, G; Soubrié, P; Steinberg, R | 1 |
| Chesselet, MF; Eberle-Wang, K; Lucki, I; Parry, TJ | 1 |
| Bardgett, ME; Csernansky, JG; Harding, J; Jackson, JL; Salaris, SL | 1 |
| Adams, CE; Johnson, RG; Nagamoto, H; Rose, GM; Stevens, KE | 1 |
| Oganesian, GA; Titkov, ES; Vataev, SI | 1 |
| Bardgett, ME; Csernansky, JG; Jackson, JL; Taylor, BM | 1 |
| Bardgett, ME; Csernansky, CA; Csernansky, JG; Roe, DL | 1 |
| Baca, SM; Hyde, TM; Jaskiw, GE; Kleinman, JE; Murray, AM; Spurney, CF | 1 |
| Choe, BK; Kim, SK; Kwon, GY; Shin, SW | 1 |
| Berger, SP; Fox, L; Ho, LB; Reid, MS | 1 |
| Bardgett, ME; Henry, JD | 1 |
| Gmiro, VE; Gorbunova, LV; Lukomskaia, NIa; Rukoiatkina, NI | 1 |
| Gmiro, VE; Gorbunova, LV; Lukomskaya, NY; Rukoyatkina, NI | 1 |
| Ando, N; Morimoto, K; Ninomiya, T; Suwaki, H; Watanabe, T | 1 |
| Cosi, C; Newman-Tancredi, A; Rollet, K; Tesori, V; Waget, A | 1 |
| Chen, L; Sokabe, M | 1 |
2 review(s) available for haloperidol and kainic acid
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
Topics: Animals; Apomorphine; Cerebellum; Corpus Striatum; Cyclic GMP; Dopamine; Enkephalins; gamma-Aminobutyric Acid; Haloperidol; Harmaline; Isoniazid; Kainic Acid; Neural Pathways; Rats | 1978 |
74 other study(ies) available for haloperidol and kainic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Image-based high-throughput drug screening targeting the intracellular stage of Trypanosoma cruzi, the agent of Chagas' disease.
Topics: Animals; Cattle; Cell Line; Cell Line, Tumor; Chagas Disease; Drug Evaluation, Preclinical; Hepatocytes; High-Throughput Screening Assays; Humans; Image Processing, Computer-Assisted; Muscle, Skeletal; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Dopamine-synthesis and tyrosine-hydroxylase are regulated by independent DA-receptor mediated mechanisms.
Topics: Animals; Apomorphine; Cerebral Cortex; Corpus Striatum; Dopamine; Haloperidol; Kainic Acid; Rats; Receptors, Dopamine; Tyrosine 3-Monooxygenase | 1978 |
Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation.
Topics: Animals; Antipsychotic Agents; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enzyme Activation; Haloperidol; Kainic Acid; Kinetics; Rats; Receptors, Dopamine; Tyrosine 3-Monooxygenase | 1978 |
Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity.
Topics: Animals; Apomorphine; Body Weight; Dopamine; gamma-Aminobutyric Acid; Glutamates; Haloperidol; Kainic Acid; Male; Neurotransmitter Agents; Rats; Substantia Nigra; Time Factors | 1978 |
3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Haloperidol; Homovanillic Acid; Kainic Acid; Male; Phenylacetates; Rats; Tyramine | 1978 |
Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.
Topics: Animals; Butaclamol; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Haloperidol; Kainic Acid; Rats; Receptors, Dopamine; Spiperone | 1979 |
Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Cerebellar Cortex; Cerebellum; Corpus Striatum; Cyclic GMP; Dopamine; Haloperidol; Harmaline; Isoniazid; Kainic Acid; Male; Pyrrolidines; Rats | 1978 |
GABA-receptors in the substantia nigra controlling cyclic-GMP in the cerebellar cortex.
Topics: Animals; Cerebellar Cortex; Corpus Striatum; Cyclic GMP; gamma-Aminobutyric Acid; Haloperidol; Kainic Acid; Muscimol; Rats; Receptors, Drug; Substantia Nigra | 1979 |
Neuronal activity of the substantia nigra (pars compacta) after injection of kainic acid into the caudate nucleus.
Topics: Animals; Caudate Nucleus; Electric Stimulation; Haloperidol; Kainic Acid; Male; Neurons; Pyrrolidines; Rats; Substantia Nigra; Trifluoperazine | 1979 |
Unitary dopaminergic receptor composed of cooperatively linked agonist and antagonist sub-unit binding sites.
Topics: Animals; Apomorphine; Binding Sites; Corpus Striatum; Female; Haloperidol; Hydroxydopamines; Kainic Acid; Kinetics; Rats; Receptors, Dopamine; Spiperone; Subcellular Fractions | 1979 |
Evidence that a nigral gabaergic--cholinergic balance controls posture.
Topics: Animals; Apomorphine; Arecoline; Behavior, Animal; Carbachol; Catalepsy; Choline O-Acetyltransferase; gamma-Aminobutyric Acid; Haloperidol; Humans; Kainic Acid; Male; Posture; Rats; Receptors, Cholinergic; Receptors, Muscarinic; Scopolamine; Stereotyped Behavior; Substantia Nigra | 1979 |
Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
Topics: Animals; Apomorphine; Bicuculline; Corpus Striatum; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Humans; Hydroxydopamines; Kainic Acid; Male; Neurons; Picrotoxin; Rats; Stereotyped Behavior; Substantia Nigra | 1979 |
Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum.
Topics: Adenylyl Cyclases; Afferent Pathways; Animals; Axons; Cerebral Cortex; Corpus Striatum; Haloperidol; Kainic Acid; Rats; Receptors, Dopamine | 1978 |
Functional interaction between receptors for dopamine antagonists and GABA central receptors.
Topics: Animals; Chlorpromazine; Corpus Striatum; Dopamine Antagonists; gamma-Aminobutyric Acid; Haloperidol; Injections; Kainic Acid; Male; Rats; Receptors, Dopamine; Receptors, Drug; Substantia Nigra; Time Factors | 1978 |
Stimulation of the nigrostriatal dopamine system inhibits both heat production and heat loss mechanisms in rats.
Topics: Animals; Body Temperature; Body Temperature Regulation; Corpus Striatum; Dopamine; Dopamine Antagonists; Electric Stimulation; Haloperidol; Injections; Kainic Acid; Male; Medial Forebrain Bundle; Neural Pathways; Oxidopamine; Rats; Rats, Sprague-Dawley; Skin Temperature; Substantia Nigra | 1992 |
Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine Agents; Electric Stimulation; Haloperidol; Kainic Acid; Male; Methyltyrosines; Nerve Endings; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride; Tyrosine 3-Monooxygenase | 1991 |
Dopamine modulates the kinetics of ion channels gated by excitatory amino acids in retinal horizontal cells.
Topics: Analysis of Variance; Animals; Cells, Cultured; Dopamine; Glutamates; Glutamic Acid; Haloperidol; Ion Channels; Kainic Acid; Kinetics; Neurotransmitter Agents; Perches; Retina | 1990 |
DNQX blockade of amphetamine behavioral sensitization.
Topics: Amphetamine; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Haloperidol; Kainic Acid; Male; Mice; Mice, Inbred Strains; N-Methylaspartate; Quinoxalines; Seizures; Stereotyped Behavior | 1991 |
Failure of sigma-receptor ligands to reduce the excitatory actions of N-methyl-DL-aspartate on rat spinal neurons in-vivo.
Topics: Animals; Aspartic Acid; Haloperidol; In Vitro Techniques; Kainic Acid; Ligands; N-Methylaspartate; Neurons; Oxadiazoles; Piperidines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, delta; Spinal Cord; Stereoisomerism | 1990 |
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors.
Topics: Animals; Aspartic Acid; Guanidines; Haloperidol; In Vitro Techniques; Iontophoresis; Kainic Acid; Male; N-Methylaspartate; Neurons; Oxadiazoles; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Spiperone | 1990 |
Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats.
Topics: Animals; Behavior, Animal; Caudate Nucleus; Dialysis; Dopamine; Glutamates; Haloperidol; Kainic Acid; Male; N-Methylaspartate; Nucleus Accumbens; Piperazines; Quinoxalines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Glutamate; Receptors, Neurotransmitter | 1990 |
Neuropeptide Y selectively potentiates N-methyl-D-aspartate-induced neuronal activation.
Topics: Animals; Aspartic Acid; Drug Synergism; Haloperidol; Iontophoresis; Kainic Acid; Male; N-Methylaspartate; Neurons; Neuropeptide Y; Oxadiazoles; Quisqualic Acid; Rats; Rats, Inbred Strains | 1990 |
Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alkaloids; Animals; Axons; Benzazepines; Catfishes; Cells, Cultured; Diglycerides; Dopamine; Ergolines; Haloperidol; Kainic Acid; Kinetics; Protein Kinase C; Quinpirole; Receptors, Dopamine; Retina; Staurosporine; Tetradecanoylphorbol Acetate | 1990 |
Chronic modification of dopaminergic transmission and its effects on binding characteristics of dopamine transporter ligand 3H-GBR 12783 in the striatum.
Topics: Animals; Corpus Striatum; Dopamine; Haloperidol; Hydroxydopamines; Kainic Acid; Male; Mice; Oxidopamine; Piperazines; Rats; Rats, Inbred Strains; Synaptic Transmission | 1989 |
Glutamate and dopamine modulate synaptic plasticity in horizontal cell dendrites of fish retina.
Topics: Animals; Carps; Cyprinidae; Dendrites; Dopamine; Glutamates; Glutamic Acid; Haloperidol; In Vitro Techniques; Kainic Acid; Lighting; Microscopy, Electron; Neuronal Plasticity; Retina; Synapses | 1988 |
Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. II. Dopaminergic systems.
Topics: Amphetamines; Animals; Apomorphine; Corpus Striatum; Dopamine; Female; Fetus; Haloperidol; Kainic Acid; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2 | 1988 |
Alpha 2-adrenoceptors modulate kainic acid-induced limbic seizures.
Topics: Animals; Brain Chemistry; Clonidine; Diazepam; Haloperidol; Kainic Acid; Male; Metergoline; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Seizures | 1985 |
Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Glutamine; Haloperidol; Kainic Acid; Kinetics; Limbic System; Male; Proglumide; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra | 1987 |
3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
Topics: Animals; Benzazepines; Dopamine; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Haloperidol; Kainic Acid; Male; Membranes; Rats; Receptors, Dopamine; Substantia Nigra; Sulpiride; Synapses | 1986 |
Study of the morphological, electrophysiological and behavioral effects of unilateral kainic acid injection into the cat's substantia nigra.
Topics: Animals; Apomorphine; Brain Mapping; Cats; Dopamine; Haloperidol; Kainic Acid; Motor Activity; Neural Pathways; Substantia Nigra; Superior Colliculi; Thalamic Nuclei | 1987 |
The effect of bilateral kainic acid-induced lateral habenula lesions on dopamine-mediated behaviors.
Topics: Animals; Brain Mapping; Diencephalon; Dopamine; Haloperidol; Kainic Acid; Male; Rats; Stereotyped Behavior | 1987 |
Dopamine inhibits calcium-independent gamma-[3H]aminobutyric acid release induced by kainate and high K+ in the fish retina.
Topics: Animals; Aspartic Acid; Bicuculline; Calcium; Dopamine; Fishes; gamma-Aminobutyric Acid; Haloperidol; Kainic Acid; N-Methylaspartate; Oxadiazoles; Picrotoxin; Potassium; Pyrrolidines; Quisqualic Acid; Retina; Serotonin | 1985 |
Effect of various centrally acting drugs on the efflux of dopamine metabolites from the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Biological Transport, Active; Brain; Brain Stem; Central Nervous System Agents; Chloral Hydrate; Chlorpromazine; Corpus Striatum; Dopamine; Frontal Lobe; Haloperidol; Homovanillic Acid; Kainic Acid; Male; Olfactory Bulb; Oxotremorine; Pargyline; Phenylacetates; Probenecid; Rats | 1986 |
Antidromic discharge property of meso-accumbens dopaminergic VTA neurons in rats.
Topics: Action Potentials; Animals; Dopamine; Electric Stimulation; Haloperidol; Kainic Acid; Male; Neural Conduction; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains; Reaction Time; Septal Nuclei; Tegmentum Mesencephali | 1985 |
Effect of systemic and intrastriatal injections of haloperidol on striatal dopamine and DOPAC concentrations in rats pretreated by section of nigrostriatal fibres.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Feedback; Glutamate Decarboxylase; Haloperidol; Kainic Acid; Male; Nerve Degeneration; Phenylacetates; Rats; Receptors, Dopamine; Substantia Nigra | 1980 |
Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
Topics: 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dihydroxyphenylalanine; Haloperidol; Kainic Acid; Male; Pyrrolidines; Rats; Receptors, Dopamine | 1980 |
[Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
Topics: Animals; Apomorphine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Haloperidol; Homovanillic Acid; Kainic Acid; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1981 |
Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
Topics: Animals; Apomorphine; Caudate Nucleus; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Haloperidol; Kainic Acid; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1982 |
Dopamine modulates cholecystokinin release in neostriatum.
Topics: Animals; Apomorphine; Calcium; Caudate Nucleus; Cholecystokinin; Dopamine; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Kainic Acid; Putamen; Rats; Receptors, Dopamine; Tetrodotoxin; Veratridine | 1983 |
The effect of striatal lesions in the chick on haloperidol-potentiated tonic immobility.
Topics: Animals; Animals, Newborn; Chickens; Corpus Striatum; Haloperidol; Kainic Acid; Male; Motor Activity | 1983 |
Bilateral injection of kainic acid into the rat striatum potentiates morphine, arecoline and pilocarpine but not haloperidol catalepsy.
Topics: Animals; Arecoline; Catalepsy; Corpus Striatum; Drug Interactions; Haloperidol; Humans; Injections; Kainic Acid; Male; Morphine; Pilocarpine; Pyrrolidines; Rats; Rats, Inbred Strains | 1982 |
Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy.
Topics: Animals; Catalepsy; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Haloperidol; Humans; Hydroxydopamines; Kainic Acid; Male; Medial Forebrain Bundle; Rats; Receptors, Dopamine; Substantia Nigra | 1981 |
Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
Topics: Animals; Catalepsy; Cerebral Cortex; Corpus Striatum; Haloperidol; Humans; Kainic Acid; Male; Neural Pathways; Rats; Receptors, Dopamine; Synaptic Membranes | 1980 |
Kainic acid injections in the striatum alter the cataleptic and locomotor effects of drugs influencing dopaminergic and cholinergic systems.
Topics: Animals; Catalepsy; Corpus Striatum; Dopamine; Haloperidol; Humans; Injections; Kainic Acid; Male; Motor Activity; Parasympathetic Nervous System; Pyrrolidines; Rats; Rats, Inbred Strains | 1981 |
Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
Topics: Animals; Apomorphine; Catalepsy; Corpus Striatum; Haloperidol; Humans; Injections; Kainic Acid; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Time Factors | 1982 |
Antagonism of intrastriatal and intravenous kainic acid by 1-nuciferine: comparison with various anticonvulsants and GABAmimetics.
Topics: Animals; Aporphines; Baclofen; Behavior, Animal; Choline O-Acetyltransferase; Corpus Striatum; Diazepam; Excitatory Amino Acid Antagonists; Haloperidol; Injections; Kainic Acid; Male; Phenobarbital; Pyrrolidines; Rats; Seizures | 1980 |
Kainic acid induced lesion of ventral tegmental area: locomotor effect of apomorphine.
Topics: Animals; Apomorphine; Haloperidol; Kainic Acid; Male; Motor Activity; Pyrrolidines; Rats; Receptors, Dopamine | 1980 |
Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
Topics: Animals; Apomorphine; Dopamine; gamma-Aminobutyric Acid; Haloperidol; In Vitro Techniques; Kainic Acid; Male; Potassium; Rats; Receptors, Dopamine; Substantia Nigra; Tritium | 1981 |
The behavioural effects of systemically administered kainic acid: a pharmacological analysis.
Topics: Animals; Behavior, Animal; Bicuculline; Dose-Response Relationship, Drug; Drug Interactions; gamma-Aminobutyric Acid; Haloperidol; Kainic Acid; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Time Factors | 1981 |
Circling behavior following unilateral kainic acid injections into rat striatum.
Topics: Animals; Brain; Cerebral Cortex; Corpus Striatum; Female; Glutamates; Haloperidol; Hydroxydopamines; Kainic Acid; Motor Activity; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation; Seizures; Substantia Nigra | 1981 |
Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.
Topics: Animals; Corpus Striatum; Dopamine; Evoked Potentials; Haloperidol; Kainic Acid; Male; Morphine; Nerve Degeneration; Neural Pathways; Neurons; Rats; Receptors, Dopamine; Substantia Nigra | 1980 |
The striatal dopaminergic catalepsy mechanism is not necessary for the expression of pontine catalepsy produced by carbachol injections into the pontine reticular formation.
Topics: Animals; Basal Ganglia; Carbachol; Catalepsy; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Agonists; Haloperidol; Injections; Kainic Acid; Male; Neostriatum; Pons; Rats; Reticular Formation; Substantia Nigra; Ventromedial Hypothalamic Nucleus | 1995 |
The amino-terminus of substance P mimics and MK-801 attenuates the effects of capsaicin on nociception and kainic acid-induced behavior in the mouse.
Topics: Analysis of Variance; Animals; Capsaicin; Dizocilpine Maleate; Haloperidol; Kainic Acid; Male; Mice; Pain; Peptide Fragments; Piperazines; Receptors, N-Methyl-D-Aspartate; Substance P | 1993 |
MK-801 inhibits the effects of capsaicin in the adult mouse by an action involving phencyclidine (PCP) sites not linked to NMDA activity.
Topics: Animals; Behavior, Animal; Capsaicin; Dizocilpine Maleate; Haloperidol; Injections, Spinal; Kainic Acid; Male; Mice; Pain Measurement; Pain Threshold; Peptide Fragments; Piperazines; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Substance P | 1993 |
Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Drug Synergism; Guanidines; Haloperidol; Injections, Spinal; Kainic Acid; Male; Mice; N-Methylaspartate; Peptide Fragments; Piperazines; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Receptors, sigma; Spinal Cord; Substance P; Up-Regulation | 1993 |
Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens.
Topics: Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Electrodes; Haloperidol; Kainic Acid; Male; Nucleus Accumbens; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin | 1995 |
Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats.
Topics: Animals; Apomorphine; Benzazepines; Dopamine Agents; Dyskinesia, Drug-Induced; Haloperidol; Kainic Acid; Male; Mouth Diseases; Rats; Rats, Sprague-Dawley; Sulpiride; Thalamic Nuclei | 1994 |
MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate.
Topics: 2-Amino-5-phosphonovalerate; Animals; Behavior, Animal; Capsaicin; Dizocilpine Maleate; Haloperidol; Kainic Acid; Male; Mice; N-Methylaspartate; Nociceptors; Phencyclidine; Piperazines; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine; Receptors, sigma; Spinal Cord | 1993 |
The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine.
Topics: Animals; Caudate Nucleus; Clozapine; Corpus Striatum; Dopamine; Dopamine Agonists; Haloperidol; Injections, Intraventricular; Kainic Acid; Male; Nucleus Accumbens; Putamen; Rats; Rats, Sprague-Dawley | 1997 |
Kainic acid lesions in adult rats as a model of schizophrenia: changes in auditory information processing.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Auditory Perception; Disease Models, Animal; Electrodes, Implanted; Electrophysiology; Evoked Potentials; Excitatory Amino Acid Agonists; Haloperidol; Hippocampus; Injections, Intraventricular; Kainic Acid; Male; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Schizophrenic Psychology | 1998 |
[Corticostriatal relations in the waking-sleep cycle of normal rats and in pathology].
Topics: Acoustic Stimulation; Animals; Catalepsy; Caudate Nucleus; Cerebral Cortex; Disease Susceptibility; Dopamine Antagonists; Excitatory Amino Acid Agonists; Haloperidol; Kainic Acid; Rats; Rats, Wistar; Reference Values; Seizures; Sleep; Time Factors; Wakefulness | 1997 |
The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine.
Topics: Amphetamine; Animals; Antipsychotic Agents; Clozapine; Dopamine Uptake Inhibitors; Excitatory Amino Acid Agonists; Haloperidol; Kainic Acid; Male; Motor Activity; Rats; Rats, Sprague-Dawley | 1998 |
Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss.
Topics: Animals; Antipsychotic Agents; Brain; Brain Diseases; Cell Count; Clozapine; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Haloperidol; Kainic Acid; Limbic System; Male; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 1998 |
Differential effects of haloperidol and clozapine on ionotropic glutamate receptors in rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Analysis of Variance; Animals; Aspartic Acid; Binding Sites; Brain; Clozapine; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Haloperidol; Kainic Acid; Male; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate | 1999 |
Expression of neuropeptide Y by glutamatergic stimulation in rat C6 glioma cells.
Topics: Animals; Dopamine; Gene Expression Regulation, Neoplastic; Glioma; Glutamic Acid; Haloperidol; Kainic Acid; Muscimol; Neuropeptide Y; Pentylenetetrazole; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 2000 |
Nicotine stimulation of extracellular glutamate levels in the nucleus accumbens: neuropharmacological characterization.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acid Transport System X-AG; Animals; Aspartic Acid; ATP-Binding Cassette Transporters; Biological Transport; Denervation; Dicarboxylic Acids; Dopamine; Extracellular Space; Glutamic Acid; Haloperidol; Kainic Acid; Kinetics; Male; Mecamylamine; Microdialysis; Neurotransmitter Uptake Inhibitors; Nicotine; Nucleus Accumbens; Oxidopamine; Pyrrolidines; Rats; Rats, Sprague-Dawley | 2000 |
Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anesthetics, Local; Animals; Benzazepines; Brain Chemistry; Cycloleucine; Dextroamphetamine; Dopamine Agents; Dopamine Antagonists; Excitatory Amino Acid Agonists; Genes, Immediate-Early; Glutamic Acid; Haloperidol; Hippocampus; Kainic Acid; Lidocaine; Locomotion; Male; N-Methylaspartate; Neural Pathways; Neuroprotective Agents; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1999 |
[Ability of novel non-competitive glutamate receptor blocking agents to weaken motor disorders in animals].
Topics: Animals; Anticonvulsants; Ataxia; Benzene Derivatives; Catalepsy; Cations; Cyclohexanes; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Haloperidol; Kainic Acid; Mice; N-Methylaspartate; Parkinsonian Disorders; Seizures; Structure-Activity Relationship | 2001 |
The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals.
Topics: Animals; Ataxia; Behavior, Animal; Catalepsy; Diamines; Disease Models, Animal; Dizocilpine Maleate; Dopamine Antagonists; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Haloperidol; Kainic Acid; Memantine; Mice; Mice, Inbred Strains; N-Methylaspartate; Quaternary Ammonium Compounds; Seizures; Structure-Activity Relationship; Time Factors | 2003 |
Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Chemistry; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electrochemistry; Epilepsy, Temporal Lobe; Haloperidol; In Vitro Techniques; Kainic Acid; Male; Methamphetamine; Microdialysis; Motor Activity; Psychotic Disorders; Rats; Rats, Sprague-Dawley | 2004 |
Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.
Topics: Aminopyridines; Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Haloperidol; Kainic Acid; Male; Mice; Mice, Inbred C57BL; Piperazines; Piperidines; Pyridines; Quinolones; Receptor, Serotonin, 5-HT1A; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin Antagonists; Thiazoles | 2005 |
Presynaptic modulation of synaptic transmission by pregnenolone sulfate as studied by optical recordings.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Aconitine; Analysis of Variance; Animals; Benzylidene Compounds; Bicuculline; Bungarotoxins; Calcium; Calcium Channel Blockers; Diagnostic Imaging; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Ethylenediamines; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Haloperidol; Hippocampus; In Vitro Techniques; Kainic Acid; Male; Neurons; Nicotinic Agonists; Nicotinic Antagonists; Pregnenolone; Presynaptic Terminals; Pyridines; Rats; Rats, Wistar; Synaptic Transmission; Tetrodotoxin; Time Factors | 2005 |